Are you overlooking Orphan drug savings opportunities? A closer look at the orphan drug exclusion, manufacturer discount availability, and hospital purchasing practices can reveal potential untapped hospital savings. Explore practical ways to evaluate 340B savings opportunities while protecting compliance and financial accountability.
Read More:- Beyond the Drug Price: How Hospitals Can Identify Overlooked Orphan Drug Savings Opportunities